Heat probe thermocoagulation as a substitute for surgical intervention to arrest massive peptic ulcer hemorrhage

An experience in 153 cases

H. J. Lin, F. Y. Lee, C. Y. Chan, Z. C. Huang, W. M. Kang, C. H. Lee, S. D. Lee, Y. T. Tsai

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

In a period of 2 years 7 months, we performed heat probe (HP) thermocoagulation in 153 cases of massive peptic ulcer hemorrhage. The male/female sex ratio was 125/28. The average age was 57.6 ± 1.3 years (mean ± SEM; range, 17 to 88). There were 69 cases (45.1%) of spurting hemorrhage, 50 cases (32.7%) of oozing hemorrhage, and 34 cases (22.2%) of nonbleeding visible vessels. Seventy-seven patients (50.3%) were in shock before therapy. After therapy we obtained initial success in 147 cases (96.1%). Rebleeding episodes occurred in 23 patients (15.6%) within 1 month after therapy. Nineteen patients received a second therapy, and treatment in 15 of these cases (78.9%) was ultimately successful. Finally, treatment in 142 cases (92.8%) was ultimately successful. The duration of hospitalization was 6.3 ± 0.4 days (mean ± SEM). After discharge all patients were followed at the outpatient department for at least 1 month. Sixty-seven patients were followed endoscopically for at least 2 to 3 months after therapy. Fifty-six patients (83.6%) had a healed scar at the previous bleeding site 2 months after therapy, and 62 patients (92.5%) had a healed scar 3 months after therapy. We conclude that HP thermocoagulation is an ideal and reliable modality of therapeutic endoscopy in arrest of massive peptic ulcer hemorrhage. HP thermocoagulation may become the first choice of therapy for massive peptic ulcer bleeding in the near future.

Original languageEnglish
Pages (from-to)18-21
Number of pages4
JournalSurgery
Volume108
Issue number1
Publication statusPublished - 1990
Externally publishedYes

Fingerprint

Peptic Ulcer Hemorrhage
Electrocoagulation
Hot Temperature
Hemorrhage
Therapeutics
Cicatrix
Convulsive Therapy
Patient Discharge
Sex Ratio
Peptic Ulcer
Endoscopy
Hospitalization

ASJC Scopus subject areas

  • Surgery

Cite this

Lin, H. J., Lee, F. Y., Chan, C. Y., Huang, Z. C., Kang, W. M., Lee, C. H., ... Tsai, Y. T. (1990). Heat probe thermocoagulation as a substitute for surgical intervention to arrest massive peptic ulcer hemorrhage: An experience in 153 cases. Surgery, 108(1), 18-21.

Heat probe thermocoagulation as a substitute for surgical intervention to arrest massive peptic ulcer hemorrhage : An experience in 153 cases. / Lin, H. J.; Lee, F. Y.; Chan, C. Y.; Huang, Z. C.; Kang, W. M.; Lee, C. H.; Lee, S. D.; Tsai, Y. T.

In: Surgery, Vol. 108, No. 1, 1990, p. 18-21.

Research output: Contribution to journalArticle

Lin, HJ, Lee, FY, Chan, CY, Huang, ZC, Kang, WM, Lee, CH, Lee, SD & Tsai, YT 1990, 'Heat probe thermocoagulation as a substitute for surgical intervention to arrest massive peptic ulcer hemorrhage: An experience in 153 cases', Surgery, vol. 108, no. 1, pp. 18-21.
Lin, H. J. ; Lee, F. Y. ; Chan, C. Y. ; Huang, Z. C. ; Kang, W. M. ; Lee, C. H. ; Lee, S. D. ; Tsai, Y. T. / Heat probe thermocoagulation as a substitute for surgical intervention to arrest massive peptic ulcer hemorrhage : An experience in 153 cases. In: Surgery. 1990 ; Vol. 108, No. 1. pp. 18-21.
@article{14b0d8d41920496eb35183229318d820,
title = "Heat probe thermocoagulation as a substitute for surgical intervention to arrest massive peptic ulcer hemorrhage: An experience in 153 cases",
abstract = "In a period of 2 years 7 months, we performed heat probe (HP) thermocoagulation in 153 cases of massive peptic ulcer hemorrhage. The male/female sex ratio was 125/28. The average age was 57.6 ± 1.3 years (mean ± SEM; range, 17 to 88). There were 69 cases (45.1{\%}) of spurting hemorrhage, 50 cases (32.7{\%}) of oozing hemorrhage, and 34 cases (22.2{\%}) of nonbleeding visible vessels. Seventy-seven patients (50.3{\%}) were in shock before therapy. After therapy we obtained initial success in 147 cases (96.1{\%}). Rebleeding episodes occurred in 23 patients (15.6{\%}) within 1 month after therapy. Nineteen patients received a second therapy, and treatment in 15 of these cases (78.9{\%}) was ultimately successful. Finally, treatment in 142 cases (92.8{\%}) was ultimately successful. The duration of hospitalization was 6.3 ± 0.4 days (mean ± SEM). After discharge all patients were followed at the outpatient department for at least 1 month. Sixty-seven patients were followed endoscopically for at least 2 to 3 months after therapy. Fifty-six patients (83.6{\%}) had a healed scar at the previous bleeding site 2 months after therapy, and 62 patients (92.5{\%}) had a healed scar 3 months after therapy. We conclude that HP thermocoagulation is an ideal and reliable modality of therapeutic endoscopy in arrest of massive peptic ulcer hemorrhage. HP thermocoagulation may become the first choice of therapy for massive peptic ulcer bleeding in the near future.",
author = "Lin, {H. J.} and Lee, {F. Y.} and Chan, {C. Y.} and Huang, {Z. C.} and Kang, {W. M.} and Lee, {C. H.} and Lee, {S. D.} and Tsai, {Y. T.}",
year = "1990",
language = "English",
volume = "108",
pages = "18--21",
journal = "Surgery",
issn = "0039-6060",
publisher = "Mosby Inc.",
number = "1",

}

TY - JOUR

T1 - Heat probe thermocoagulation as a substitute for surgical intervention to arrest massive peptic ulcer hemorrhage

T2 - An experience in 153 cases

AU - Lin, H. J.

AU - Lee, F. Y.

AU - Chan, C. Y.

AU - Huang, Z. C.

AU - Kang, W. M.

AU - Lee, C. H.

AU - Lee, S. D.

AU - Tsai, Y. T.

PY - 1990

Y1 - 1990

N2 - In a period of 2 years 7 months, we performed heat probe (HP) thermocoagulation in 153 cases of massive peptic ulcer hemorrhage. The male/female sex ratio was 125/28. The average age was 57.6 ± 1.3 years (mean ± SEM; range, 17 to 88). There were 69 cases (45.1%) of spurting hemorrhage, 50 cases (32.7%) of oozing hemorrhage, and 34 cases (22.2%) of nonbleeding visible vessels. Seventy-seven patients (50.3%) were in shock before therapy. After therapy we obtained initial success in 147 cases (96.1%). Rebleeding episodes occurred in 23 patients (15.6%) within 1 month after therapy. Nineteen patients received a second therapy, and treatment in 15 of these cases (78.9%) was ultimately successful. Finally, treatment in 142 cases (92.8%) was ultimately successful. The duration of hospitalization was 6.3 ± 0.4 days (mean ± SEM). After discharge all patients were followed at the outpatient department for at least 1 month. Sixty-seven patients were followed endoscopically for at least 2 to 3 months after therapy. Fifty-six patients (83.6%) had a healed scar at the previous bleeding site 2 months after therapy, and 62 patients (92.5%) had a healed scar 3 months after therapy. We conclude that HP thermocoagulation is an ideal and reliable modality of therapeutic endoscopy in arrest of massive peptic ulcer hemorrhage. HP thermocoagulation may become the first choice of therapy for massive peptic ulcer bleeding in the near future.

AB - In a period of 2 years 7 months, we performed heat probe (HP) thermocoagulation in 153 cases of massive peptic ulcer hemorrhage. The male/female sex ratio was 125/28. The average age was 57.6 ± 1.3 years (mean ± SEM; range, 17 to 88). There were 69 cases (45.1%) of spurting hemorrhage, 50 cases (32.7%) of oozing hemorrhage, and 34 cases (22.2%) of nonbleeding visible vessels. Seventy-seven patients (50.3%) were in shock before therapy. After therapy we obtained initial success in 147 cases (96.1%). Rebleeding episodes occurred in 23 patients (15.6%) within 1 month after therapy. Nineteen patients received a second therapy, and treatment in 15 of these cases (78.9%) was ultimately successful. Finally, treatment in 142 cases (92.8%) was ultimately successful. The duration of hospitalization was 6.3 ± 0.4 days (mean ± SEM). After discharge all patients were followed at the outpatient department for at least 1 month. Sixty-seven patients were followed endoscopically for at least 2 to 3 months after therapy. Fifty-six patients (83.6%) had a healed scar at the previous bleeding site 2 months after therapy, and 62 patients (92.5%) had a healed scar 3 months after therapy. We conclude that HP thermocoagulation is an ideal and reliable modality of therapeutic endoscopy in arrest of massive peptic ulcer hemorrhage. HP thermocoagulation may become the first choice of therapy for massive peptic ulcer bleeding in the near future.

UR - http://www.scopus.com/inward/record.url?scp=0025369016&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0025369016&partnerID=8YFLogxK

M3 - Article

VL - 108

SP - 18

EP - 21

JO - Surgery

JF - Surgery

SN - 0039-6060

IS - 1

ER -